← Open Payments lookup

KISHORE VARADA: Open Payments

NPI 1477735272 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,421 in 49 payments from 10 companies in 2025. Trend: 2023 $1,084 · 2024 $1,796 · 2025 $1,421

Food & beverage: $1,421
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$354
Axsome Therapeutics, Inc.6$308
Neurocrine BioSciences, Inc.6$261
Alkermes, Inc.5$128
Otsuka America Pharmaceutical, Inc.4$89
Supernus Pharmaceuticals, Inc.3$78
E.R. Squibb & Sons, L.L.C.2$65
Takeda Pharmaceuticals U.S.A., Inc.2$58
Vanda Pharmaceuticals Inc.2$57
Lundbeck LLC1$24

Products named: CAPLYTA, Auvelity, INGREZZA, REXULTI, ARISTADA, Qelbree, COBENFY, TRINTELLIX.

Industry payments across WA — which companies pay providers there.